2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Intermediate Uveitis: new trials by email Literature Review of Intermediate Uveitis trials Research Report on Intermediate Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| Sirolimus as Therapeutic Approach to Uveitis Sirolimus (rapamycin) - Uveitis, Intermediate Uveitis | Phase 1 | Completed | Johns Hopkins University | 30 | 2009-07-01 | 2018-08-20 |
Panuveitis (2) · Uveitis (2) · Uveitis, Intermediate (2) · Uveitis, Posterior (2) · Choroidal Effusions (1) · Giant Cell Arteritis (1) · Inflammation (1) · Ophthalmia, Sympathetic (1)
Eye Diseases (2) · Uveal Diseases (2) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Choroid Diseases (1) · Eye Abnormalities (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Adrenal Cortex Hormones (1) · Sirolimus (1) · Triamcinolone (1) · Triamcinolone Acetonide (1)
Clearside Biomedical, Inc. (1) · Johns Hopkins University (1)
United States (2)
Quan D Nguyen, MD, MSc (1) · Thomas Ciulla, MD (1)